These healthtech startups in Singapore have raised more than US$10 million in their latest funding round

Thanks to its government great support for innovation, Singapore has been a hotbed for healthtech startups.

Within the e27 startup database, we are able to note down more than 55 startups in Singapore that are working to build and provide solutions for the health and medical sectors.

In recent years, investment in healthtech in Southeast Asia has been increasing rapidly with some startups raising more than US$10 million in their latest funding round.

The following is a list of such startups (excluding those who are raising undisclosed funding rounds):

DocDoc
Funding Stage: US$13 million venture round
Investor(s): Adamas Finance Asia Limited

Operating in eight countries with more than 23,000 doctors, DocDoc aims to help patients find the right care at the right time.

Also Read: Bill & Melinda Gates Foundation invests in Indonesian healthtech startup Halodoc

Biofourmis Pte. Ltd.
Funding Stage: US$35 million in Series B
Investor(s): Sequoia India

Biofurmis aims to personalise healthcare and empower people with tools to make healthcare and lifestyle data actionable and understandable.

Docquity
Funding Stage: US$11 million in Series B
Investor(s): Itochu Corporation, Singapore Press Holdings

Docquity provides a by-invitation, doctors-only professional network.

CXA Group
Funding Stage: US$25 million venture round
Investor(s): HSBC, Telkom Indonesia, MDI Ventures, Singtel Innov8, Sumitomo Corporation Equity Asia

Founded in 2013 by industry veteran Rosaline Chow Koo, CXA brings evidence-based wellness into the workplace to improve employee health and control healthcare costs.

AWAK Technologies
Funding Stage: US$11.2 million venture round
Investor(s): Accuron Technologies

The company develops a patented sorbent technology which aims to revolutionise dialysis by reducing the amount of dialysate needed for treatment.

Also Read: Beyond the hospital: Challenges and opportunities in Indonesian healthtech scene

ASLAN Pharmaceuticals
Funding Stage: US$12 million venture round
Investor(s): BioVeda Capital

ASLAN Pharmaceuticals is an oncology-focussed biotechnology company developing a portfolio of immunotherapies and targeted drugs, focusing on Asia prevalent tumour types.

—

The e27 Startup Database connects the community to the hottest internet companies in Asia. We encourage startups to visit their profile and regularly update their information.

Image Credit: Ali Yahya on Unsplash

The post Your cheat sheet to the top-funded healthtech startups in Singapore appeared first on e27.